Inventor · disambiguated record
Yuanshan Yao
Also filed as: YAO YUANSHAN
8 granted patents·5 pending applications·10 citations·filing 2014–2023
76Inventor score
Files withCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD3SHANGHAI MEIYUE BIOTECH DEV CO LTD3MINGHUI PHARMACEUTICAL SHANGHAI LTD2BRESLOW RONALD1CHINA RESOURCES PHARMACEUTICAL HOLDINGS COMPANY LTD1
Top patents by PatentIndex Score
13 records- 0179US9890136B2Selective HDAC6 inhibitorsBRESLOW RONALD·Filed 2014·Granted Feb 13, 2018·7 cites·22 claims
- 0277US9856264B2Isoquinolinesulfonyl derivative as RHO kinase inhibitorMEDSHINE DISCOVERY INC·Filed 2015·Granted Jan 2, 2018·3 cites·19 claims
- 0360US10626100B2Selective HDAC6 inhibitorsUNIV COLUMBIA·Filed 2017·Granted Apr 21, 2020·0 cites·20 claims
- 0457US2025197414A1Salt form and crystal form of vanin enzyme inhibitor, method for preparing same, and use thereofSHANGHAI MEIYUE BIOTECH DEV CO LTD·Filed 2023·Application pending·0 cites
- 0555US2024139327A1Prodrug compound, preparation method therefor and use thereofMINGHUI PHARMACEUTICAL HANGZHOU LTD·Filed 2022·Application pending·0 cites
- 0652US11034681B2Crystal form of indole derivative and preparation method and use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Jun 15, 2021·0 cites·20 claims
- 0749US2024124479A1Pyrimidine carboxamide compound and use thereofSHANGHAI MEIYUE BIOTECH DEV CO LTD·Filed 2021·Application pending·0 cites
- 0848US2024083873A1Pyrimidine carboxamide compound and application thereofSHANGHAI MEIYUE BIOTECH DEV CO LTD·Filed 2021·Application pending·0 cites
- 0945US11155559B2Sulfonyl-substituted isoquinolines as inhibitors of RHO kinase and hERG potassium channel activityCHINA RESOURCES PHARMACEUTICAL HOLDINGS COMPANY LTD·Filed 2018·Granted Oct 26, 2021·0 cites·11 claims
- 1043US10800765B2Indole derivative used as CRTH2 inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Oct 13, 2020·0 cites·15 claims
- 1143US2023099739A1Jak kinase inhibitor and preparation and application thereofMINGHUI PHARMACEUTICAL SHANGHAI LTD·Filed 2021·Application pending·0 cites
- 1240US12384786B2Cyclic molecules as Bruton's tyrosine kinase inhibitorMINGHUI PHARMACEUTICAL SHANGHAI LTD·Filed 2020·Granted Aug 12, 2025·0 cites·11 claims
- 1338US11524958B2Tricyclic compound as CRTH2 inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Dec 13, 2022·0 cites·15 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →